SEC Form 4 · accession 0001209191-16-102414

HeartWare International, Inc. · HTWR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Medical Officer

Period of report

Feb 23, 2016

Accepted (ET)

Feb 25, 2016 · 5:18 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001389072

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Feb 23, 2016	M	875	$0.00	A	875	D
Common Stock^F2,F3	Feb 24, 2016	S	875	$32.38	D	0	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Restricted Stock Unit^F4	—	Feb 23, 2016	M	875	D	Feb 23, 2016	Feb 23, 2016	Common Stock	875	19,875	D

F1On February 23, 2015, the reporting person was granted restricted stock units to acquire 3,500 shares of HeartWare International common stock. The award vests in four equal installments commencing on February 23, 2016. On February 23, 2016, 875 shares of common stock were issued to the reporting person.
F2These shares were sold pursuant to a pre-arranged trading plan in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. A portion of the sale proceeds were utilized to pay taxes related to the vesting of restricted stock units and receipt of the related shares reported on this Form 4.
F3The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $32.01 to $32.55. The reporting person has provided the issuer and will provide any security holder of the issuer or the SEC Staff, upon request, information regarding the number of shares sold at each price within the range.
F4Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.